Kangstem Biotech Co., Ltd.

Informe acción KOSDAQ:A217730

Capitalización de mercado: ₩127.8b

Kangstem Biotech Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jong-Cheon Na

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Sep 24
Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Is Kangstem Biotech (KOSDAQ:217730) Using Debt Sensibly?

May 24
Is Kangstem Biotech (KOSDAQ:217730) Using Debt Sensibly?

Investors Don't See Light At End Of Kangstem Biotech Co., Ltd.'s (KOSDAQ:217730) Tunnel

Mar 06
Investors Don't See Light At End Of Kangstem Biotech Co., Ltd.'s (KOSDAQ:217730) Tunnel

Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Feb 17
Is Kangstem Biotech (KOSDAQ:217730) Weighed On By Its Debt Load?

Would Shareholders Who Purchased Kang Stem Biotech's (KOSDAQ:217730) Stock Three Years Be Happy With The Share price Today?

Dec 26
Would Shareholders Who Purchased Kang Stem Biotech's (KOSDAQ:217730) Stock Three Years Be Happy With The Share price Today?

CEO

Jong-Cheon Na

no data

Permanencia

Jong-Cheon Na serves as Chief Executive Officer of Kangstem Biotech Co., Ltd.